Literature DB >> 23560843

Quality of reporting and its correlates among randomized controlled trials on acupuncture for cancer pain: application of the CONSORT 2010 Statement and STRICTA.

Liming Lu1, Muxi Liao, Jingchun Zeng, Jun He.   

Abstract

This study aims to analyze the quality of reporting and its correlates in randomized controlled trials (RCTs) on acupuncture for cancer pain. Quality of reporting for included papers was assessed against a subset of criteria adapted from the CONSORT 2010 statement and STRICTA. An overall quality score (OQS) and a combined key methodologic index score (MIS) was calculated for each trial. Factors associated with OQS and MIS were then identified. A total of 32 RCTs were included in the full text. The median OQS based on the CONSORT Statement and STRICTA was 4.0 and 0, respectively. The significant predictors for CONSORT OQS were year of publication and nationality of authors, for STRICTA it was nationality of authors and for MIS it was publication language. The quality of reporting in RCTs on acupuncture for cancer pain was poor. This indicates that RCTs on acupuncture for cancer pain need substantial improvement.

Entities:  

Mesh:

Year:  2013        PMID: 23560843     DOI: 10.1586/era.13.27

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  8 in total

Review 1.  Acupuncture for symptom management in cancer care: an update.

Authors:  M Kay Garcia; Jennifer McQuade; Richard Lee; Robin Haddad; Michael Spano; Lorenzo Cohen
Journal:  Curr Oncol Rep       Date:  2014-12       Impact factor: 5.075

2.  Impact evaluation of CONSORT and STRICTA guidelines on reporting quality for randomized controlled trials of acupuncture conducted in China.

Authors:  Li-Ming Lu; Jun He; Jing-Chun Zeng; Mu-Xi Liao; Chao Jia; Hai-Hua Pan
Journal:  Chin J Integr Med       Date:  2016-03-21       Impact factor: 1.978

Review 3.  Assessment of Completeness of Reporting in Randomized Controlled Trials of Acupuncture Therapy for Chronic Obstructive Pulmonary Disease.

Authors:  Huanrong Ruan; Hailong Zhang; Zhenzhen Feng; Xuanlin Li; Weihong Han; Yimei Si; Jiansheng Li
Journal:  Int J Gen Med       Date:  2022-05-31

4.  STRICTA: is it time to do more?

Authors:  Lizhou Liu; Margot Skinner; Suzanne M McDonough; Priya Kannan; George David Baxter
Journal:  BMC Complement Altern Med       Date:  2015-06-20       Impact factor: 3.659

5.  Quality of randomized controlled trials reporting in the treatment of melasma conducted in China.

Authors:  Zhiwei Chen; Yuchi Chen; Jingchun Zeng; Yang Wang; Teng Ye; Qiaochu Zhou; Xiaojing Du; Wenting Su; Zhishan Ding
Journal:  Trials       Date:  2015-04-12       Impact factor: 2.279

Review 6.  Effectiveness of acupuncture for cancer pain: protocol for an umbrella review and meta-analyses of controlled trials.

Authors:  Yihan He; Yihong Liu; Brian H May; Anthony Lin Zhang; Haibo Zhang; ChuanJian Lu; Lihong Yang; Xinfeng Guo; Charlie Changli Xue
Journal:  BMJ Open       Date:  2017-12-10       Impact factor: 2.692

7.  Assessing the quality of reports about randomized controlled trials of scalp acupuncture combined with another treatment for stroke.

Authors:  Young-Nim You; Myung-Rae Cho; Jae-Hong Kim; Ju-Hyung Park; Gwang-Cheon Park; Min-Yeong Song; Jin-Bong Choi; Jae-Young Han
Journal:  BMC Complement Altern Med       Date:  2017-09-06       Impact factor: 3.659

8.  Assessing the quality of reports about randomized controlled trials of scalp acupuncture treatment for vascular dementia.

Authors:  Young-Nim You; Myung-Rae Cho; Ju-Hyung Park; Gwang-Cheon Park; Min-Yeong Song; Jin-Bong Choi; Chang-Su Na; Jae-Young Han; Jeong-Cheol Shin; Jae-Hong Kim
Journal:  Trials       Date:  2017-05-02       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.